We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Two Big-Ticket Hemophilia Gene Therapies Would Be Worth the Cost, ICER Says
Two Big-Ticket Hemophilia Gene Therapies Would Be Worth the Cost, ICER Says
Two gene replacement therapies to combat hemophilia are worth multimillion dollar price tags because they would eliminate the need for ongoing treatment with high-priced anticoagulant drugs, says the Institute for Clinical and Economic Review (ICER).